| |
|
|
|
iBio Inc.  
|
|
0.71 -0.01 (-0.01%) |
07-22 10:26 |
|
Open: |
0.72 |
Pre close: |
0.72 |
Target:
|
0.94
|
|
High: |
0.724 |
Low: |
0.6901 |
Resistance:
|
0.80
0.88
|
|
Volume: |
13,116 |
Market Cap: |
14M |
Support:
|
0.68
0.57
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.71
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.71  |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.81 |
Stochastic Oscillator |
%K(14,3):
|
52.38 |
|
MA(250): |
0.81 |
%D(3): |
48.73 |
|
Average Volume(K) |
3-Month: |
4304
|
52-Week |
High:
|
1.10 |
|
10-Days: |
4061 |
Low: |
0.50 |
|
RSI |
RSI(14):
|
47.00 |
Change(%): |
-15.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.052 |
Return on Equity (ttm) |
-316.8 |
Shares Out. (M) |
19.70 |
|
EPS Est. Current Year |
-0.150 |
Return on Assets (ttm) |
-29.4 |
Shares Float (M) |
10.50 |
|
EPS Est. Next Year |
-0.200 |
PEG Ratio |
0.00 |
% Held by Insiders |
45.24 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
575.6 |
% Held by Institutions |
8.01 |
|
Forward EPS |
1.#IO |
Gross Profit (p.s.) |
0.023 |
Shares Short (K) |
245 |
|
Book Value (p.s.) |
0.350 |
EBITDA (p.s.) |
-0.708 |
P/E |
-0.68 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.06 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-12.96 |
P/S |
177300000.00 |
|
Operating Margin |
-1193.38 |
Levered Free Cash Flow
(M) |
-7.85 |
P/CF |
-1.09 |
|
|
|
|
|
|
